Efficacy and Safety of Upfront Oral Triple Lipid-Lowering Therapy: A Systematic Review and Single-Arm Meta-Analysis - PubMed
4 hours ago
- #cardiovascular disease
- #lipid-lowering therapy
- #LDL-cholesterol
- The study evaluates the efficacy and safety of upfront oral triple lipid-lowering therapy.
- Key drugs involved include Bempedoic acid and Ezetimibe.
- Focuses on LDL-cholesterol reduction and goal attainment.
- References recent guidelines and studies on dyslipidaemia management.
- Includes a simulation using the SANTORINI study cohort.
- Discusses therapeutic optimization in atherosclerotic cardiovascular disease patients.
- Examines early initiation of PCSK9 inhibitors in acute coronary syndrome.